Treace James T. - 15 Nov 2021 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa Taylor as Attorney-in-fact for James T. Treace
Issuer symbol
TMCI
Transactions as of
15 Nov 2021
Net transactions value
-$1,545,515
Form type
4
Filing time
17 Nov 2021, 19:32:31 UTC
Next filing
24 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale $397,689 -19,485 -0.88% $20.41 2,185,773 15 Nov 2021 Direct F1, F2
transaction TMCI Common Stock Sale $118,076 -5,515 -0.25% $21.41 2,180,258 15 Nov 2021 Direct F1, F3
transaction TMCI Common Stock Sale $521,500 -25,000 -1.1% $20.86 2,155,258 16 Nov 2021 Direct F1, F4
transaction TMCI Common Stock Sale $508,250 -25,000 -1.2% $20.33 2,130,258 17 Nov 2021 Direct F1, F5
transaction TMCI Common Stock Gift $0 -200,000 -9.4% $0.000000 1,930,258 27 Oct 2021 Direct F6
transaction TMCI Common Stock Gift $0 -200,000 -10% $0.000000 1,730,258 27 Oct 2021 Direct F7
transaction TMCI Common Stock Gift $0 -600,000 -35% $0.000000 1,130,258 12 Nov 2021 Direct F8
holding TMCI Common Stock 600,000 15 Nov 2021 By spouse
holding TMCI Common Stock 1,478,946 15 Nov 2021 J&A Group, LLC F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.98 to $20.95 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.99 to $21.87 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.46 to $21.18 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.87 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 Gift transfer to a natural person.
F7 Gift transfer to a second natural person.
F8 Gift transfer to reporting person's spouse.
F9 James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company.